• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NRIX

NRIX

Nurix Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD15.48

-0.89 (-5.44%)

Rating:C-

Company Profile

CEO

Arthur T. Sands

IPO Date

2020-07-24

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$16.31

Prev. Close

$16.37

Day Low

$15.45

Day High

$16.34

52W Low

$8.20

52W High

$22.50

Market Cap

$1.34B

Volume

1.30M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

21.5%

Avg Negative

1.4%

Avg Neutral

77.0%

News Feed

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

GlobeNewsWire·6/21/2021·↑ positive

Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors

GlobeNewsWire·6/1/2021·↑ positive

Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress

GlobeNewsWire·5/21/2021·↑ positive

Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

GlobeNewsWire·4/13/2021·↑ positive

Nurix Therapeutics Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/7/2021·↑ positive

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

GlobeNewsWire·3/16/2021·↑ positive

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

GlobeNewsWire·3/10/2021·↑ positive

Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·3/9/2021·↓ negative

Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

GlobeNewsWire·3/9/2021·↑ positive

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewsWire·3/4/2021·↑ positive